W. Rathmell
Last active: 4/27/2021

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.

Wood CG, Ferguson JE, Parker JS, Moore DT, Whisenant JG, Maygarden SJ, Wallen EM, Kim WY, Milowsky MI, Beckermann KE, Davis NB, Haake SM, Karam JA, Bortone DS, Vincent BG, Powles T, Rathmell WK
JCI Insight. 2020 5 (22)

PMID: 33208553 · PMCID: PMC7710285 · DOI:10.1172/jci.insight.132852

MeSH Terms (20)

Adult Aged Angiogenesis Inhibitors Biomarkers, Tumor Carcinoma, Renal Cell Case-Control Studies Female Follow-Up Studies Humans Indazoles Kidney Neoplasms Male Middle Aged Neoadjuvant Therapy Prognosis Pyrimidines Retrospective Studies Sulfonamides Survival Rate Transcriptome

Connections (1)

This publication is referenced by other Labnodes entities:

Links